Skip to main content

Articles

Page 1 of 20

  1. Buprenorphine and naloxone are first-line medications for people who use opioids (PWUO). Buprenorphine can reduce opioid use and cravings, help withdrawal symptoms, and reduce risk of opioid overdose. Naloxone...

    Authors: David Dadiomov, Maria Bolshakova, Melania Mikhaeilyan and Rebecca Trotzky-Sirr
    Citation: Harm Reduction Journal 2022 19:69
  2. Women who use heroin and other drugs (WWUD) are a key population with elevated risk of physical and sexual violence perpetrated by intimate partners and non-partners. While housing instability has been shown t...

    Authors: Claire Silberg, Samuel Likindikoki, Jessie Mbwambo, Kristin Mmari and Haneefa T. Saleem
    Citation: Harm Reduction Journal 2022 19:68
  3. Individuals with substance use disorder often encounter law enforcement due to drug use-related criminal activity. Traditional policing approaches may not be effective for reducing recidivism and improving out...

    Authors: Alice Zhang, Joseph A. Balles, Jennifer E. Nyland, Thao H. Nguyen, Veronica M. White and Aleksandra E. Zgierska
    Citation: Harm Reduction Journal 2022 19:67
  4. The aim of this study was to critically analyse information concerning the relationship between alcohol and food consumption provided via alcohol industry (AI) funded and non-AI-funded health-oriented websites...

    Authors: Anna Ramsbottom, May C. I. van Schalkwyk, Lauren Carters-White, Yasmine Benylles and Mark Petticrew
    Citation: Harm Reduction Journal 2022 19:66
  5. As the opioid overdose crisis persists and take-home naloxone (THN) programmes expand, it is important that the intervention is targeted towards those most likely to use it. We examined THN program participant...

    Authors: Desiree Eide, Philipp Lobmaier and Thomas Clausen
    Citation: Harm Reduction Journal 2022 19:65
  6. Traditional heroin-assisted treatment in Switzerland consists of oral and injectable diacetylmorphine (pharmaceutical heroin) administration. To date, no suitable treatment option is available for patients who...

    Authors: Maximilian Meyer, Jean N. Westenberg, Johannes Strasser, Kenneth M. Dürsteler, Undine E. Lang, Michael Krausz and Marc Vogel
    Citation: Harm Reduction Journal 2022 19:63
  7. The overdose crisis in the USA remains a growing and urgent public health concern. Over 108,000 people died due to overdose during 2021. Fatal and non-fatal overdoses are under-reported in the USA due to curre...

    Authors: Kasey Claborn, Suzannah Creech, Fiona N. Conway, Nina M. Clinton, Katlyn T. Brinkley, Elizabeth Lippard, Tristan Ramos, Jake Samora, Aaron Miri and Justin Benzer
    Citation: Harm Reduction Journal 2022 19:62
  8. This study aimed to evaluate the feasibility of using the HIV self-test in high-risk Iranian groups (MSM, FSWs, and TGs).

    Authors: Ghobad Moradi, Elnaz Ezzati Amini, Azam Valipour, Katayoon Tayeri, Parvin Afsar Kazerooni, Leila Molaeipour and Yousef Moradi
    Citation: Harm Reduction Journal 2022 19:61
  9. Negative encounters with law enforcement—direct and vicarious—fuel mistrust. When considered as part of the ‘risk environment’ in public health and harm reduction research, law enforcement mistrust may have br...

    Authors: Laura M. Johnson, Paul G. Devereux and Karla D. Wagner
    Citation: Harm Reduction Journal 2022 19:60
  10. People who inject drugs (PWID) may be at elevated risk of adverse outcomes from SARS-CoV-2 infection; however, data on COVID-19 vaccine uptake among PWID are scarce. This study aimed to determine COVID-19 vacc...

    Authors: Jenny Iversen, Handan Wand, Robert Kemp, Jude Bevan, Myf Briggs, Kate Patten, Sue Heard and Lisa Maher
    Citation: Harm Reduction Journal 2022 19:59
  11. Hepatitis C (HCV) infection has been rising in the suburban and rural USA, mainly via injection-based transmission. Injection and sexual networks are recognized as an important element in fostering and prevent...

    Authors: Mary Ellen Mackesy-Amiti, Joshua Falk, Carl Latkin, Maggie Kaufmann, Leslie Williams and Basmattee Boodram
    Citation: Harm Reduction Journal 2022 19:58
  12. Nicotine pharmacokinetic assessments of electronic nicotine delivery systems (ENDS) are crucial to understand their ability to provide an alternative to cigarette smoking. Subjective effects data also strongly...

    Authors: Ian M. Fearon, Karin Gilligan, Ryan G. N. Seltzer and Willie McKinney
    Citation: Harm Reduction Journal 2022 19:57
  13. Global commitment to achieving hepatitis C virus (HCV) elimination has enhanced efforts in improving access to direct-acting antiviral (DAA) treatments for people who inject drugs (PWID). Scale-up of efforts t...

    Authors: Heidi Coupland, Charles Henderson, Janice Pritchard-Jones, Shih-Chi Kao, Sinead Sheils, Regina Nagy, Martin O’Donnell, Paul S. Haber and Carolyn A. Day
    Citation: Harm Reduction Journal 2022 19:56
  14. Opioid-related overdose deaths have surged in the USA over the last two decades. Overdose fatalities are preventable with the timely administration of naloxone. Syringe service programs (SSP) have pioneered co...

    Authors: Lynn D. Wenger, Maya Doe-Simkins, Eliza Wheeler, Lee Ongais, Terry Morris, Ricky N. Bluthenthal, Alex H. Kral and Barrot H. Lambdin
    Citation: Harm Reduction Journal 2022 19:55
  15. Hospital patients who use drugs may require prolonged parenteral antimicrobial therapy administered through a vascular access device (VAD). Clinicians’ concerns that patients may inject drugs into these device...

    Authors: Hannah L. Brooks, Ginetta Salvalaggio, Bernadette Pauly, Kathryn Dong, Tania Bubela, Marliss Taylor and Elaine Hyshka
    Citation: Harm Reduction Journal 2022 19:54
  16. In Kyrgyzstan and other Eastern European and Central Asian countries, injection drug use and HIV-related intersectional stigma undermines HIV prevention efforts, fueling a rapidly expanding HIV epidemic. The K...

    Authors: Laramie R. Smith, Natalia Shumskaia, Ainura Kurmanalieva, Thomas L. Patterson, Dan Werb, Anna Blyum, Angel B. Algarin, Samantha Yeager and Javier Cepeda
    Citation: Harm Reduction Journal 2022 19:53
  17. Worsening of the overdose crisis in the USA has been linked to the continuing proliferation of non-pharmaceutical fentanyl (NPF). The recent wave of NPF spread in the USA has been fueled by an increased presen...

    Authors: Raminta Daniulaityte, Kaylin Sweeney, Seol Ki, Bradley N. Doebbeling and Natasha Mendoza
    Citation: Harm Reduction Journal 2022 19:52
  18. Despite recent rises in fatal overdoses involving multiple substances, there is a paucity of knowledge about stimulant co-use patterns among people who use opioids (PWUO) or people being treated with medicatio...

    Authors: Abeed Sarker, Mohammed Ali Al-Garadi, Yao Ge, Nisha Nataraj, Christopher M. Jones and Steven A. Sumner
    Citation: Harm Reduction Journal 2022 19:51
  19. When the novel coronavirus pandemic emerged in March 2020, many settings across Canada and the USA were already contending with an existing crisis of drug overdoses due to the toxic unregulated drug supply. In...

    Authors: Mana Moshkforoush, Kora DeBeck, Rupinder Brar, Nadia Fairbairn, Zishan Cui, M.-J. Milloy, Jane Buxton, Tanis Oldenburger, Will McLellan, Perry Kendall, Kali Sedgemore, Dean Wilson, Thomas Kerr and Kanna Hayashi
    Citation: Harm Reduction Journal 2022 19:50
  20. The increasing prevalence of highly potent, illicitly manufactured fentanyl and its analogues (IMF) in the USA is exacerbating the opioid epidemic which has worsened during the COVID-19 pandemic. Narcan® (nalo...

    Authors: Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Neyla Darwaza, Diane Ito, Jessica Shoaff and Josh Epstein
    Citation: Harm Reduction Journal 2022 19:49
  21. Police in Canada have become main responders to behavioural health concerns in the community—a role that disproportionately harms people who use drugs (PWUD). Recent calls to defund the police emphasize the ne...

    Authors: Amanda Butler, Naomi Zakimi and Alissa Greer
    Citation: Harm Reduction Journal 2022 19:48
  22. The coronavirus pandemic (COVID-19) exacerbated risks for adverse health consequences among people who inject drugs by reducing access to sterile injection equipment, HIV testing, and syringe services programs...

    Authors: Jennifer L. Glick, Suzanne M. Grieb, Samantha J. Harris, Brian W. Weir, Katherine C. Smith, Tyler Puryear, Rebecca Hamilton White and Sean T. Allen
    Citation: Harm Reduction Journal 2022 19:47
  23. British Columbia (BC) has been in a state of public health emergency since 2016, due to the unprecedented numbers of fatal and non-fatal drug toxicity (i.e. overdose) events. Methamphetamine detection in illic...

    Authors: Jenny Corser, Heather Palis, Mathew Fleury, Jess Lamb, Kurt Lock, Jenny McDougall, Amiti Mehta, Cheri Newman, Heather Spence and Jane A. Buxton
    Citation: Harm Reduction Journal 2022 19:46
  24. The emergence of widespread amphetamine-type stimulants (ATSs) usage has created significant challenges for drug control and treatment policies in Southeast Asian countries. This study analyses the development...

    Authors: Mai Thi Ngoc Tran, Michael P. Dunne, Giang Minh Le, Hoe Dinh Han, Trang Thu Nguyen, Hai Thanh Luong, Quang Hung Luong, Ha Nguyen Pham and Philip Baker
    Citation: Harm Reduction Journal 2022 19:45
  25. Vancouver, Canada, and Lisbon, Portugal, are both celebrated for their world-leading harm reduction policies and programs and regarded as models for other cities contending with the effects of increasing level...

    Authors: Joana Canêdo, Kali-olt Sedgemore, Kelly Ebbert, Haleigh Anderson, Rainbow Dykeman, Katey Kincaid, Claudia Dias, Diana Silva, Reith Charlesworth, Rod Knight and Danya Fast
    Citation: Harm Reduction Journal 2022 19:43
  26. To offer a critical reflection on an impoverished neighborhood in Vancouver, Canada, and their access to oral health care. A review of how a lack of publicly funded oral health care affects the most vulnerable...

    Authors: Ehsan Jozaghi, Vandu, Russ Maynard, Yasaman Khoshnoudian and Mario A. Brondani
    Citation: Harm Reduction Journal 2022 19:42
  27. In the context of the current U.S. injection drug use epidemic, targeted public health harm reduction strategies have traditionally focused on overdose prevention and reducing transmission of blood-borne viral...

    Authors: Alexander Hrycko, Pedro Mateu-Gelabert, Courtney Ciervo, Rebecca Linn-Walton and Benjamin Eckhardt
    Citation: Harm Reduction Journal 2022 19:41
  28. This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing t...

    Authors: Julia A. Silano, Carla Treloar, Kyle Leadbeatter, Sandy Davidson and Justine Doidge
    Citation: Harm Reduction Journal 2022 19:40
  29. Glassware can be an effective vehicle to recruit customers, revive brands, build profits and increase alcohol consumption by capitalising on the immediacy of glassware to the point of consumption. The design o...

    Authors: David M. Troy, Olivia M. Maynard, Matthew Hickman, Marcus R. Munafò and Angela S. Attwood
    Citation: Harm Reduction Journal 2022 19:39
  30. People who use drugs (PWUD) are at high risk of experiencing indirect harms of measures implemented to curb the spread of COVID-19, given high reliance on services and social networks. This study aimed to docu...

    Authors: Nanor Minoyan, Stine Bordier Høj, Camille Zolopa, Dragos Vlad, Julie Bruneau and Sarah Larney
    Citation: Harm Reduction Journal 2022 19:38
  31. Adolescence and young adulthood is an important period for substance use initiation and related harms. In the context of the ongoing opioid crisis, the risks for youth (ages 16–29) who use opioids are particul...

    Authors: Kirsten Marchand, Oonagh Fogarty, Katrina Marie Pellatt, Kayly Vig, Jordan Melnychuk, Christina Katan, Faria Khan, Roxanne Turuba, Linda Kongnetiman, Corinne Tallon, Jill Fairbank, Steve Mathias and Skye Barbic
    Citation: Harm Reduction Journal 2022 19:37
  32. Amphetamine-type stimulants (ATS) are globally widely used. Scientific literature generally defines four phases of substance use (initiation, continuation, increase and decrease); however, there is limited und...

    Authors: Nienke Liebregts, Rafaela Rigoni, Benjamin Petruželka, Miroslav Barták, Magdalena Rowicka, Heike Zurhold and Katrin Schiffer
    Citation: Harm Reduction Journal 2022 19:36
  33. Community-based harm reduction programs reduce morbidity and mortality associated with drug use. While hospital-based inpatient addiction consult services can also improve outcomes for patients using drugs, in...

    Authors: Ghulam Karim Khan, Leah Harvey, Samantha Johnson, Paul Long, Simeon Kimmel, Cassandra Pierre and Mari-Lynn Drainoni
    Citation: Harm Reduction Journal 2022 19:35
  34. The harmful use of alcohol is one of the leading health risk factors for people’s health worldwide, but some populations, like people who experience homelessness, are more vulnerable to its detrimental effects...

    Authors: Rossio Motta-Ochoa, Natalia Incio-Serra, Hélène Poliquin, Sue-Ann MacDonald, Christophe Huỳnh, Philippe-Benoit Côté, Jean-Sébastien Fallu and Jorge Flores-Aranda
    Citation: Harm Reduction Journal 2022 19:34
  35. Supervised consumption services (SCS), intended to reduce morbidity and mortality among people who inject drugs, have been implemented in a variety of delivery models. We describe and compare access to and upt...

    Authors: Tanner Nassau, Gillian Kolla, Kate Mason, Shaun Hopkins, Paula Tookey, Elizabeth McLean, Dan Werb and Ayden Scheim
    Citation: Harm Reduction Journal 2022 19:33
  36. The resurgence of heroin use and the misuse of pharmaceutical opioids are some of the reasons for a worldwide increase in opioid dependence. Opioid Medication Therapies (OMT) have amply demonstrated their effi...

    Authors: Morgane Guillou Landreat, Antoine Dany, Gaelle Challet Bouju, Edouard-Jules Laforgue, J. Cholet, Juliette Leboucher, Jean Benoit Hardouin, Caroline Victorri Vigneau and Marie Grall Bronnec
    Citation: Harm Reduction Journal 2022 19:31
  37. Community-based participatory research (CBPR) is increasingly standard practice for critical qualitative health research with young people who use(d) drugs in Vancouver, Canada. One aim of CBPR in this context...

    Authors: Madison Thulien, Haleigh Anderson, Shane Douglas, Rainbow Dykeman, Amanda Horne, Ben Howard, Kali Sedgemore, Reith Charlesworth and Danya Fast
    Citation: Harm Reduction Journal 2022 19:30
  38. Opioid-related harms, including fatal and non-fatal overdoses, rose dramatically during the COVID-19 pandemic and presented unique challenges during outbreaks in congregate settings such as shelters. People wh...

    Authors: Brendan Lew, Claire Bodkin, Robin Lennox, Timothy O’Shea, Gillian Wiwcharuk and Suzanne Turner
    Citation: Harm Reduction Journal 2022 19:29
  39. Previous work has demonstrated that cannabis laws have had a disproportionate impact on Māori, the Indigenous people of Aotearoa New Zealand. In 2019, the New Zealand Government amended cannabis laws, providin...

    Authors: Wetini Rapana, Taylor Winter, Ririwai Fox, Benjamin C. Riordan, Rajas Kulkarni, Waikaremoana Waitoki and Damian Scarf
    Citation: Harm Reduction Journal 2022 19:28
  40. Drug use is one of the most common public health problems globally. This study was done to analyze the agenda-setting of policies related to substance use disorder treatment in Iran since 1979.

    Authors: Saeid Mirzaei, Vahid Yazdi-Feyzabadi, Mohammad Hossein Mehrolhassani, Nouzar Nakhaee and Nadia Oroomiei
    Citation: Harm Reduction Journal 2022 19:27
  41. Lockdown measures during the first wave of the COVID-19 pandemic in France led to serious public health concerns over people who use illicit drugs, especially in terms of mental health. We assessed changes in ...

    Authors: Salim Mezaache, Cécile Donadille, Victor Martin, Maëla Le Brun Gadelius, Laurent Appel, Bruno Spire, Laelia Briand Madrid, Martin Bastien and Perrine Roux
    Citation: Harm Reduction Journal 2022 19:26
  42. This study examines the effects of COVID-19 related restrictions on the supply of illicit drugs, drug-use behaviour among people who use drugs (PWUD) regularly (at least weekly), and drug-related service provi...

    Authors: David Otiashvili, Tamar Mgebrishvili, Ada Beselia, Irina Vardanashvili, Kostyantyn Dumchev, Tetiana Kiriazova and Irma Kirtadze
    Citation: Harm Reduction Journal 2022 19:25
  43. Over the last decade, one-month alcohol abstinence campaigns (OMACs) have been implemented within the general population in an increasing number of countries. We identified the published studies reporting data...

    Authors: Julia de Ternay, Pierre Leblanc, Philippe Michel, Amine Benyamina, Mickael Naassila and Benjamin Rolland
    Citation: Harm Reduction Journal 2022 19:24
  44. The development of harm reduction has been limited in many areas of Sweden. This study aims to understand the implications that this has for the life circumstances and risk management of people who use drugs i...

    Authors: Julie Holeksa
    Citation: Harm Reduction Journal 2022 19:23
  45. Despite increased availability of take-home naloxone, many people who use opioids do so in unprotected contexts, with no other person who might administer naloxone present, increasing the likelihood that an ov...

    Authors: Alex S. Bennett, Joy Scheidell, Jeanette M. Bowles, Maria Khan, Alexis Roth, Lee Hoff, Christina Marini and Luther Elliott
    Citation: Harm Reduction Journal 2022 19:20